Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.12
Delayed Data
As of Dec 06
 +0.13 / +2.61%
Today’s Change
3.42
Today|||52-Week Range
6.31
+21.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$442.5M

Company Description

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.

Contact Information

Progenics Pharmaceuticals, Inc.
One World Trade Center
New York New York 1000
P:(646) 975-2500
Investor Relations:
(646) 975-2533

Employees

Shareholders

Other institutional43.13%
Mutual fund holders39.75%
Individual stakeholders21.84%

Top Executives

There are no executives to display.